Developmental specification of midbrain dopamine neurons and their connectivity
Dopamine neurons, residing within the ventral midbrain (VM), are essential for the control of voluntary movement, emotion and cognitive function, and are affected in a number of neurological disorders such as Parkinson’s disease, schizophrenia and addiction.
The group is interested in identifying novel regulator (including Wnts, chemokines and cell adhesion molecules) in the birth and plasticity of midbrain dopamine neurons.
Instrumental in improving our knowledge of disease etiology and the development of new therapies will be a greater understanding of how these cells are initially born and wired during embryonic development. While the past 30 years have identified a number of regulators in VM dopamine development, several events remain poorly understood.
Latest Florey news for Parkinson's
Current & emerging treatments for Parkinson’s disease: from bedside to bench
In 2014, conservative estimates indicated there were just under 70,000 people living with Parkinson’s in Australia making it the most common major movement disorder and second highest prevalence neurodegenerative condition with only dementia exceeding it.
Parkinson’s research accelerates thanks to Argyrou family grant
Dr Dominic Hare and his world class team from the worlds of chemistry, physics, neuroscience and pathology, have won the 2018 Argyrou Family Fellowship
Brain health affects all Australians. You can support our research by making a donation or a bequest.